//--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
isPartOf:"Journal of health economics"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject_exact:"Pharmaceutical industry"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Pharmaceutical industry
45
Pharmaindustrie
45
Pharmaceuticals
32
Arzneimittel
31
Arzneimittelmarkt
11
Pharmaceutical market
11
Gesundheitskosten
9
Health care costs
9
Regulation
9
Regulierung
9
Innovation
8
USA
8
United States
8
Industrial research
7
Industrieforschung
7
Preisregulierung
7
Price regulation
7
Theorie
7
Theory
7
Health insurance
6
Krankenversicherung
6
Pharmacology
6
Pharmakologie
6
Market entry
5
Markteintritt
5
Competition
4
Generic drugs
4
Generika
4
Gesetzliche Krankenversicherung
4
Gesundheitspolitik
4
Health policy
4
Public health insurance
4
Wettbewerb
4
Advertising
3
Arzneimittelrecht
3
Canada
3
Kanada
3
Patent
3
Pharmaceutical law
3
Preismanagement
3
more ...
less ...
Online availability
All
Undetermined
21
Free
1
Type of publication
All
Article
45
Type of publication (narrower categories)
All
Article in journal
45
Aufsatz in Zeitschrift
45
Language
All
English
45
Author
All
DiMasi, Joseph A.
3
Grabowski, Henry G.
3
Brekke, Kurt R.
2
Dalen, Dag Morten
2
Danzon, Patricia Munch
2
González, Paula
2
Hansen, Ronald W.
2
Lakdawalla, Darius
2
Ornaghi, Carmine
2
Pertile, Paolo
2
Siotis, Georges
2
Straume, Odd Rune
2
Abbott, Thomas A.
1
Agarwal, Ruchir
1
Anis, Aslam H.
1
Bardey, David
1
Bergman, Mats A.
1
Berndt, Ernst R.
1
Billette de Villemeur, Étienne
1
Bommier, Antoine
1
Borrescio-Higa, Florencia
1
Burman, Carl-Fredrik
1
Castanheira, Micael
1
Chao, Li-wei
1
Chatterjee, Chirantan
1
Comanor, William S.
1
Crea, Giovanni
1
Dahm, Matthias
1
Dubois, Pierre
1
Forster, Martin
1
Frutos, Maria Angeles de
1
Gailey, Adam H.
1
Galizzi, Matteo M.
1
Gamba, Simona
1
Gaulé, Patrick
1
Gibbons, Robert
1
Goldman, Dana P.
1
Gorecki, Paul K.
1
Gouglas, Dimitrios
1
Granlund, David
1
more ...
less ...
Published in...
All
Journal of health economics
NBER working paper series
112
NBER Working Paper
85
Working paper / National Bureau of Economic Research, Inc.
77
Journal of medical marketing : device, diagnostic and pharmaceutical marketing
67
International journal of pharmaceutical and healthcare marketing : IJPHM
65
Research policy : policy, management and economic studies of science, technology and innovation
52
SpringerLink / Bücher
51
The European journal of health economics : HEPAC ; health economics in prevention and care
38
Technology analysis & strategic management
37
International journal of the economics of business
35
International journal of technology management : IJTM
30
Health marketing quarterly
29
Health economics
28
Industrial and corporate change
28
Europäische Hochschulschriften / 5
27
PharmacoEconomics
27
Management science : journal of the Institute for Operations Research and the Management Sciences
26
Strategic management journal
24
Technological forecasting & social change : an international journal
23
Journal of business ethics : JOBE
21
Pharmamarketing : gesundheitsökonomische Aspekte einer innovativen Industrie am Beispiel von Deutschland, Österreich und der Schweiz
21
International journal of pharmaceutical and healthcare marketing
20
International journal of industrial organization
19
Managerial and decision economics : MDE ; the international journal of research and progress in management economics
18
R & D management
18
Journal of business research : JBR
17
Review of industrial organization : RIO
17
Applied economics
16
Gabler Edition Wissenschaft
16
International journal of production research
16
International journal of production economics
15
Research paper
15
Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies
14
Organization science : a journal of the Institute for Operations Research and the Management Sciences ; bridging disciplines to advance knowledge of organizations
14
Working Papers / eSocialSciences
14
Academy of Management journal : AMJ
13
European journal of operational research : EJOR
13
Indian pharmaceutical industry : strategies and challenges in formulations marketing
13
Journal of research in pharmaceutical economics
13
more ...
less ...
Source
All
ECONIS (ZBW)
45
Showing
1
-
45
of
45
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
Optimal intertemporal curative drug expenses : the case of hepatitis C in France
Dubois, Pierre
;
Magnac, Thierry
- In:
Journal of health economics
94
(
2024
),
pp. 1-17
Persistent link: https://www.econbiz.de/10014549771
Saved in:
2
Regulating ethical experimentation : impacts of the breakthrough therapy designation on drug R&D
Hermosilla, Manuel
- In:
Journal of health economics
94
(
2024
),
pp. 1-26
Persistent link: https://www.econbiz.de/10014549760
Saved in:
3
Pharmaceutical demand response to utilization management
Sarig, Oren
- In:
Journal of health economics
93
(
2024
),
pp. 1-18
Persistent link: https://www.econbiz.de/10014451293
Saved in:
4
An optimal mechanism to fund the development of vaccines against emerging epidemics
Snyder, Christopher M.
;
Hoyt, Kendall
;
Gouglas, Dimitrios
- In:
Journal of health economics
91
(
2023
),
pp. 1-22
Persistent link: https://www.econbiz.de/10014473414
Saved in:
5
The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets
Brekke, Kurt R.
;
Dalen, Dag Morten
;
Straume, Odd Rune
- In:
Journal of health economics
90
(
2023
),
pp. 1-17
Persistent link: https://www.econbiz.de/10014426057
Saved in:
6
The effect of RCTs on drug demand : evidence from off-label cancer drugs
McKibbin, Rebecca
- In:
Journal of health economics
90
(
2023
),
pp. 1-17
Persistent link: https://www.econbiz.de/10014426082
Saved in:
7
Information shocks and pharmaceutical firms' marketing efforts : evidence from the Chantix black box warning removal
Lawler, Emily C.
;
Skira, Meghan M.
- In:
Journal of health economics
81
(
2022
),
pp. 1-18
Persistent link: https://www.econbiz.de/10013350081
Saved in:
8
What drives innovation? : lessons from COVID-19 R&D
Agarwal, Ruchir
;
Gaulé, Patrick
- In:
Journal of health economics
82
(
2022
),
pp. 1-27
Persistent link: https://www.econbiz.de/10013350255
Saved in:
9
Paying for pharmaceuticals : uniform pricing versus two-part tariffs
Brekke, Kurt R.
;
Dalen, Dag Morten
;
Straume, Odd Rune
- In:
Journal of health economics
83
(
2022
),
pp. 1-21
Persistent link: https://www.econbiz.de/10013350399
Saved in:
10
R&D and market size : who benefits from orphan drug legislation?
Gamba, Simona
;
Magazzini, Laura
;
Pertile, Paolo
- In:
Journal of health economics
80
(
2021
),
pp. 1-22
Persistent link: https://www.econbiz.de/10013179155
Saved in:
11
Drug insurance and the strategic behavior of drug manufacturers : evergreening and generic entry after Medicare Part D
Sanzenbacher, Geoffrey
;
Wettstein, Gal
- In:
Journal of health economics
72
(
2020
),
pp. 1-13
Persistent link: https://www.econbiz.de/10012495216
Saved in:
12
Umbrella branding in pharmaceutical markets
Suppliet, Moritz
- In:
Journal of health economics
73
(
2020
),
pp. 1-13
Persistent link: https://www.econbiz.de/10012495806
Saved in:
13
The unexpected consequences of generic entry
Castanheira, Micael
;
Ornaghi, Carmine
;
Siotis, Georges
- In:
Journal of health economics
68
(
2019
),
pp. 1-22
Persistent link: https://www.econbiz.de/10012419543
Saved in:
14
Physician altruism and moral hazard : (no) evidence from finnish national prescriptions data
Crea, Giovanni
;
Galizzi, Matteo M.
;
Linnosmaa, Ismo
; …
- In:
Journal of health economics
65
(
2019
),
pp. 153-169
Persistent link: https://www.econbiz.de/10012224598
Saved in:
15
One lab, two firms, many possibilities : on R&D outsourcing in the biopharmaceutical industry
Billette de Villemeur, Étienne
;
Versaevel, Bruno
- In:
Journal of health economics
65
(
2019
),
pp. 260-283
Persistent link: https://www.econbiz.de/10012224616
Saved in:
16
Price competition in pharmaceuticals : evidence from 1303 Swedish markets
Granlund, David
;
Bergman, Mats A.
- In:
Journal of health economics
61
(
2018
),
pp. 1-12
Persistent link: https://www.econbiz.de/10011999624
Saved in:
17
Innovation in the pharmaceutical industry : new estimates of R&D costs
DiMasi, Joseph A.
;
Grabowski, Henry G.
;
Hansen, Ronald W.
- In:
Journal of health economics
47
(
2016
),
pp. 20-33
Persistent link: https://www.econbiz.de/10011580256
Saved in:
18
Private versus social incentives for pharmaceutical innovation
González, Paula
;
Macho-Stadler, Inés
; …
- In:
Journal of health economics
50
(
2016
),
pp. 286-297
Persistent link: https://www.econbiz.de/10011589125
Saved in:
19
Late-stage pharmaceutical R&D and pricing policies under two-stage regulation
Jobjörnsson, Sebastian
;
Forster, Martin
;
Pertile, Paolo
; …
- In:
Journal of health economics
50
(
2016
),
pp. 298-311
Persistent link: https://www.econbiz.de/10011589153
Saved in:
20
The heterogeneity of concentrated prescribing behavior : theory and evidence from antipsychotics
Berndt, Ernst R.
;
Gibbons, Robert
;
Kolotilin, Anton
; …
- In:
Journal of health economics
40
(
2015
),
pp. 26-39
Persistent link: https://www.econbiz.de/10011439946
Saved in:
21
Can Walmart make us healthier? Prescription drug prices and health care utilization
Borrescio-Higa, Florencia
- In:
Journal of health economics
44
(
2015
),
pp. 37-53
Persistent link: https://www.econbiz.de/10011563710
Saved in:
22
The consumer welfare implications of governmental policies and firm strategy in markets for medicines
Chatterjee, Chirantan
;
Kubo, Kensuke
;
Pingali, Viswanath
- In:
Journal of health economics
44
(
2015
),
pp. 255-273
Persistent link: https://www.econbiz.de/10011563790
Saved in:
23
Regulation of pharmaceutical prices : evidence from a reference price reform in Denmark
Kaiser, Ulrich
;
Méndez, Susan J.
;
Rønde, Thomas
; …
- In:
Journal of health economics
36
(
2014
),
pp. 174-187
Persistent link: https://www.econbiz.de/10010483181
Saved in:
24
Pharmaceutical advertising and Medicare Part D
Lakdawalla, Darius
;
Sood, Neeraj
;
Gu, Qian
- In:
Journal of health economics
32
(
2013
)
6
,
pp. 1356-1367
Persistent link: https://www.econbiz.de/10010425165
Saved in:
25
Competition in the pharmaceutical industry : how do quality differences shape advertising strategies?
Frutos, Maria Angeles de
;
Ornaghi, Carmine
;
Siotis, Georges
- In:
Journal of health economics
32
(
2013
)
1
,
pp. 268-285
Persistent link: https://www.econbiz.de/10009703521
Saved in:
26
Mergers and innovation in the pharmaceutical industry
Comanor, William S.
;
Scherer, Frederic M.
- In:
Journal of health economics
32
(
2013
)
1
,
pp. 106-113
Persistent link: https://www.econbiz.de/10009703553
Saved in:
27
Do cost-sharing and entry deregulation curb pharmaceutical innovation?
Grossmann, Volker
- In:
Journal of health economics
32
(
2013
)
5
,
pp. 881-894
Persistent link: https://www.econbiz.de/10010210741
Saved in:
28
Regulation and competition in the Taiwanese pharmaceutical market under national health insurance
Liu, Ya Ming
;
Yea-huei Kao Yang
;
Hsieh, Chee-Ruey
- In:
Journal of health economics
31
(
2012
)
3
,
pp. 471-483
Persistent link: https://www.econbiz.de/10009625666
Saved in:
29
Evergreening, patent challenges, and effective market life in pharmaceuticals
Hemphill, C. Scott
;
Sampat, Bhaven N.
- In:
Journal of health economics
31
(
2012
)
2
,
pp. 327-339
Persistent link: https://www.econbiz.de/10009625701
Saved in:
30
The value of medical and pharmaceutical interventions for reducing obesity
Michaud, Pierre-Carl
;
Goldman, Dana P.
;
Lakdawalla, Darius
- In:
Journal of health economics
31
(
2012
)
4
,
pp. 630-643
Persistent link: https://www.econbiz.de/10010219980
Saved in:
31
Regulatory policy and the location of bio-pharmaceutical foreign direct investment in Europe
Koenig, Pamina
;
McGarvie, Megan
- In:
Journal of health economics
30
(
2011
)
5
,
pp. 950-965
Persistent link: https://www.econbiz.de/10009356336
Saved in:
32
The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms
Panattoni, Laura E.
- In:
Journal of health economics
30
(
2011
)
1
,
pp. 126-145
Persistent link: https://www.econbiz.de/10009247369
Saved in:
33
Stockpiling anti-viral drugs for a pandemic : the role of Manufacturer Reserve Programs
Harrington, Joseph Emmett
;
Hsu, Edbert B.
- In:
Journal of health economics
29
(
2010
)
3
,
pp. 438-444
Persistent link: https://www.econbiz.de/10008662620
Saved in:
34
Retail price regulation and innovation : reference pricing in the pharmaceutical industry
Bardey, David
;
Bommier, Antoine
;
Jullien, Bruno
- In:
Journal of health economics
29
(
2010
)
2
,
pp. 303-316
Persistent link: https://www.econbiz.de/10003978602
Saved in:
35
Trials, tricks and transparency : how disclosure rules affect clinical knowledge
Dahm, Matthias
;
González, Paula
;
Porteiro, Nicolás
- In:
Journal of health economics
28
(
2009
)
6
,
pp. 1141-1153
Persistent link: https://www.econbiz.de/10003931673
Saved in:
36
Productivity in pharmaceutical-biotechnology R&D : the role of experience and alliances
Danzon, Patricia Munch
;
Nicholson, Sean
;
Pereira, Nuno Sousa
- In:
Journal of health economics
24
(
2005
)
2
,
pp. 317-339
Persistent link: https://www.econbiz.de/10002638165
Saved in:
37
The drug bargaining game : pharmaceutical regulation in Australia
Wright, Donald J.
- In:
Journal of health economics
23
(
2004
)
4
,
pp. 785-813
Persistent link: https://www.econbiz.de/10002216010
Saved in:
38
The price of innovation : new estimates of drug development costs
DiMasi, Joseph A.
;
Hansen, Ronald W.
;
Grabowski, Henry G.
- In:
Journal of health economics
22
(
2003
)
2
,
pp. 151-185
Persistent link: https://www.econbiz.de/10001739226
Saved in:
39
Cross-national price differences for pharmaceuticals : how large, and why?
Danzon, Patricia Munch
;
Chao, Li-wei
- In:
Journal of health economics
19
(
2000
)
2
,
pp. 159-195
Persistent link: https://www.econbiz.de/10001511446
Saved in:
40
Price regulation of pharmaceuticals in Canada
Anis, Aslam H.
- In:
Journal of health economics
17
(
1998
)
1
,
pp. 21-38
Persistent link: https://www.econbiz.de/10001235734
Saved in:
41
Price regulation in the pharmaceutical industry : prescription or placebo?
Abbott, Thomas A.
- In:
Journal of health economics
14
(
1995
)
5
,
pp. 551-565
Persistent link: https://www.econbiz.de/10001203842
Saved in:
42
Returns to R&D on new drug introductions in the 1980s
Grabowski, Henry G.
- In:
Journal of health economics
13
(
1994
)
4
,
pp. 383-406
Persistent link: https://www.econbiz.de/10001174777
Saved in:
43
Cost of innovation in the pharmaceutical industry
DiMasi, Joseph A.
(
contributor
)
- In:
Journal of health economics
10
(
1991
)
2
,
pp. 107-142
Persistent link: https://www.econbiz.de/10001109025
Saved in:
44
Barriers to entry in the Canadian pharmaceutical industry : comments, clarification and extensions
Gorecki, Paul K.
- In:
Journal of health economics
6
(
1987
)
1
,
pp. 59-72
Persistent link: https://www.econbiz.de/10001043175
Saved in:
45
A closer look at the returns and risks of pharmaceutical R&D
Joglekar, Prafulla
- In:
Journal of health economics
5
(
1986
)
2
,
pp. 153-177
Persistent link: https://www.econbiz.de/10001023736
Saved in:
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->